traded as nasdaq mdvn industry pharmaceutical industry founded 2004 headquarters san francisco california united states website medivation.com medivation is an american biopharmaceutical company focused on rapid development of novel therapies to treat serious diseases for which there are limited treatment options . medivation in collaboration with astellas is currently developing enzalutamide for multiple stages of prostate cancer and for breast cancer . on august 31 2012 medivation and astellas announced that the u.s. food and drug administration fda granted approval to xtandi enzalutamide capsules for the treatment of patients with metastatic castration resistant prostate cancer who have previously received docetaxel . xtandi is an oral once daily androgen receptor inhibitor . 1 medivation is headquartered in san francisco california and it began operations in december 2004 with the acquisition of medivation neurology inc. 2 the current ceo is david hung . 3 pfizer announced it would acquire the company in august 2016 . contents 1 company history 1.1 2010 class action lawsuit 1.2 2016 2 awards 3 external links 4 references company history edit 2010 class action lawsuit edit on march 3 2010 medivation s stock dropped 27.15 per share to close at 13.10 a 67 % one day decline on volume of 45 million shares . 4 in response a security fraud class action lawsuit was initiatied by izard nobel llp 5 alleging that medivation made false and misleading statements regarding the effectiveness of dimebon as a treatment for alzheimer s disease before being revealed that it did not meet primary and secondary goals in a phase 3 trial for patients with mild to moderate alzheimer s disease . 4 the counsel for the case was bernstein liebhard and the lead plaintiffs were initially david applestein 6 7 then catoosa fund lp . on march 22 2012 the case was dismissed with prejudice . 8 the plaintiffs appealed the dismissal in the ninth circuit court of appeals . the ninth circuit granted oral argument which will be held on friday january 17 2014 . 9 on march 7 2014 the ninth circuit affirmed the dismissal of the class action catoosa fund lp v. medivation inc. no. 12 15960 . the ninth circuit stated with the exception of the tenuous and unattributed statement that dr. schneider relates secondhand plaintiff has not pled any facts supporting an inference of actual knowledge by defendants . plaintiff relies heavily on the inference that due to their positions the defendants must have known about the unmatched nature of the study . that inference is entirely speculative and does not rise to the required strong inference ; plaintiff s allegation is not at least as compelling as any opposing inference one could draw from the facts alleged . 10 2016 edit in april the company was linked with a number of potential acquirers potentially a hostile bid from sanofi as well as links with roche astrazeneca amgen and gilead sciences . 11 astrazeneca has been reported to weigh in with an offer of 7 billion 10 billion . 12 on april 29 sanofi launched a 9.3 billion takeover offer which was rejected by the medivation board . 13 in august pfizer announced that it would acquire the company for 14 billion 14 or 81.50 per share a 21 % premium over the closing price on friday august 19 . 15 awards edit ey entrepreneur of the year 2014 national winner 16 external links edit official website medivation at crunchbase references edit law offices of howard g. smith announces class action lawsuit against medivation inc. . law offices of howard g. smith . 2010 03 03 . archived from the original on 17 november 2012 . retrieved 17 november 2012 . investor relations . medivation . archived from the original on 17 november 2012 . retrieved 17 november 2012 . management team . medivation . retrieved 17 november 2012 . a b the brualdi law firm p.c. announces class action lawsuit against medivation inc. . new york bloomberg l.p. march 12 2010 . archived from the original on 17 november 2012 . retrieved 17 november 2012 . robbins geller rudman & dowd march 9 2010 . class action complaint for violation of the federal securities laws . northern district of california izard nobel llp . archived from the original pdf on 17 november 2012 . retrieved 17 november 2012 . michael s. bigin . bernstein liebhard llp . archived from the original on 17 november 2012 . retrieved 17 november 2012 . michael s. bigin represents investors in applestein v. medivation inc. no. 10 cv 00998 emc n.d. cal . in which plaintiffs allege that defendants inflated the price of medivation stock by making false statements concerning the efficacy of its chief drug s treatment of alzheimer s disease . u. seth ottensoser . bernstein liebhard llp . archived from the original on 17 november 2012 . retrieved 17 november 2012 . u. seth ottensoser represents investors in applestein v. medivation inc. no. 10 cv 00998 emc n.d. cal . in which plaintiffs allege that defendants inflated the price of medivation stock by making false statements concerning the efficacy of its chief drug s treatment of alzheimer s disease . medivation inc. . securities class action clearinghouse . stanford law school . march 22 2012 . archived from the original on 17 november 2012 . retrieved 17 november 2012 . http cdn.ca9.uscourts.gov datastore calendaring 2013 11 13 nsf01 14rev.pdf unpublished dispositions memoranda . sanofi could go hostile with medivation bid . astrazeneca eyes xtandi windfall with potential 7b bid for medivation . joshua jamerson and noemie bisserbe 29 april 2016 . medivation rejects sanofi s 9.3 billion takeover bid . wsj . pfizer to acquire medivation for 14b gen news highlights gen . pfizer to buy cancer drug firm medivation for 14bn . bbc news . medivation . medivation ceo david hung named national ey entrepreneur of the year 2014 overall award winner . medivation.com . medivation 17 dec. 2014 . web . http investors.medivation.com releasedetail.cfm releaseid 883449 . retrieved from https en.wikipedia.org w index.php title medivation & oldid 743699262 categories companies listed on nasdaqcompanies based in san franciscotechnology companies based in the san francisco bay areabiotechnology companies of the united states navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page print export create a bookdownload as pdfprintable version languages add links this page was last modified on 10 october 2016 at 19 43 . text is available under the creative commons attribution sharealike license ; additional terms may apply . by using this site you agree to the terms of use and privacy policy . wikipedia is a registered trademark of the wikimedia foundation inc. a non profit organization . privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view